Previous close | 6.27 |
Open | 6.35 |
Bid | 6.19 x 300 |
Ask | 6.24 x 100 |
Day's range | 6.07 - 6.55 |
52-week range | 3.80 - 9.87 |
Volume | |
Avg. volume | 720,812 |
Market cap | 813.893M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Explore how Cytek Biosciences Inc navigates through revenue growth and operational expansions while addressing financial hurdles in the first quarter of 2024.
Cytek Biosciences (CTKB) delivered earnings and revenue surprises of 80% and 2.28%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
In the most recent trading session, Cytek Biosciences, Inc. (CTKB) closed at $6.01, indicating a -0.33% shift from the previous trading day.